Xenon Pharmaceuticals Inc

XENE XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

6.3B

Short interest (Jul 15)

6.6%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.31%

↑ 8.8%

Available Shares

↓ 3.7%

Price Chart

Company Overview

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001582313

Asset Type: CS

Market Data

Market Cap: $6,323,860,281

Employees: 370

Status: Active

Short Interest

Current Borrow Fee 0.31%

Range: 0.30% - 0.41%

Available Shares 1M

Range: 1.2M - 1.3M

Recent Changes

Fee Change: ↓ 12.7%

Available Change: ↑ 9.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime